BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11956513)

  • 1. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects.
    Nakamura T; Sakaeda T; Horinouchi M; Tamura T; Aoyama N; Shirakawa T; Matsuo M; Kasuga M; Okumura K
    Clin Pharmacol Ther; 2002 Apr; 71(4):297-303. PubMed ID: 11956513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects.
    Moriya Y; Nakamura T; Horinouchi M; Sakaeda T; Tamura T; Aoyama N; Shirakawa T; Gotoh A; Fujimoto S; Matsuo M; Kasuga M; Okumura K
    Biol Pharm Bull; 2002 Oct; 25(10):1356-9. PubMed ID: 12392094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.
    Goto M; Masuda S; Saito H; Uemoto S; Kiuchi T; Tanaka K; Inui K
    Pharmacogenetics; 2002 Aug; 12(6):451-7. PubMed ID: 12172213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas.
    Nakamura T; Sakaeda T; Ohmoto N; Tamura T; Aoyama N; Shirakawa T; Kamigaki T; Nakamura T; Kim KI; Kim SR; Kuroda Y; Matsuo M; Kasuga M; Okumura K
    Drug Metab Dispos; 2002 Jan; 30(1):4-6. PubMed ID: 11744604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans.
    Becquemont L; Glaeser H; Drescher S; Hitzl M; Simon N; Murdter TE; Heinkele G; Hofmann U; Schaefer C; Burk O; Verstuyft C; Eichelbaum M; Fromm MF
    Clin Pharmacol Ther; 2006 May; 79(5):449-60. PubMed ID: 16678547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects.
    Sakaeda T; Nakamura T; Horinouchi M; Kakumoto M; Ohmoto N; Sakai T; Morita Y; Tamura T; Aoyama N; Hirai M; Kasuga M; Okumura K
    Pharm Res; 2001 Oct; 18(10):1400-4. PubMed ID: 11697464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens.
    von Richter O; Burk O; Fromm MF; Thon KP; Eichelbaum M; Kivistö KT
    Clin Pharmacol Ther; 2004 Mar; 75(3):172-83. PubMed ID: 15001968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
    Cummins CL; Mangravite LM; Benet LZ
    Pharm Res; 2001 Aug; 18(8):1102-9. PubMed ID: 11587480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDR1 genotype-related duodenal absorption rate of digoxin in healthy Japanese subjects.
    Morita Y; Sakaeda T; Horinouchi M; Nakamura T; Kuroda K; Miki I; Yoshimura K; Sakai T; Shirasaka D; Tamura T; Aoyama N; Kasuga M; Okumura K
    Pharm Res; 2003 Apr; 20(4):552-6. PubMed ID: 12739761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma.
    Chen KG; Lacayo NJ; Durán GE; Wang Y; Bangs CD; Rea S; Kovacs M; Cherry AM; Brown JM; Sikic BI
    Genes Chromosomes Cancer; 2002 Aug; 34(4):372-83. PubMed ID: 12112526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression.
    Chowbay B; Li H; David M; Cheung YB; Lee EJ
    Br J Clin Pharmacol; 2005 Aug; 60(2):159-71. PubMed ID: 16042669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4.
    Dürr D; Stieger B; Kullak-Ublick GA; Rentsch KM; Steinert HC; Meier PJ; Fattinger K
    Clin Pharmacol Ther; 2000 Dec; 68(6):598-604. PubMed ID: 11180019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans.
    Giessmann T; May K; Modess C; Wegner D; Hecker U; Zschiesche M; Dazert P; Grube M; Schroeder E; Warzok R; Cascorbi I; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2004 Sep; 76(3):192-200. PubMed ID: 15371980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.
    Ameyaw MM; Regateiro F; Li T; Liu X; Tariq M; Mobarek A; Thornton N; Folayan GO; Githang'a J; Indalo A; Ofori-Adjei D; Price-Evans DA; McLeod HL
    Pharmacogenetics; 2001 Apr; 11(3):217-21. PubMed ID: 11337937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines.
    Pfrunder A; Gutmann H; Beglinger C; Drewe J
    J Pharm Pharmacol; 2003 Jan; 55(1):59-66. PubMed ID: 12625868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
    Siegmund W; Ludwig K; Giessmann T; Dazert P; Schroeder E; Sperker B; Warzok R; Kroemer HK; Cascorbi I
    Clin Pharmacol Ther; 2002 Nov; 72(5):572-83. PubMed ID: 12426521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients.
    von Ahsen N; Richter M; Grupp C; Ringe B; Oellerich M; Armstrong VW
    Clin Chem; 2001 Jun; 47(6):1048-52. PubMed ID: 11375290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age.
    Fakhoury M; Litalien C; Medard Y; Cavé H; Ezzahir N; Peuchmaur M; Jacqz-Aigrain E
    Drug Metab Dispos; 2005 Nov; 33(11):1603-7. PubMed ID: 16049125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial dosage adjustment for oral administration of tacrolimus using the intestinal MDR1 level in living-donor liver transplant recipients.
    Masuda S; Goto M; Okuda M; Ogura Y; Oike F; Kiuchi T; Tanaka K; Inui K
    Transplant Proc; 2005 May; 37(4):1728-9. PubMed ID: 15919446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.